Michelle Zappas is a clinical associate professor in the Department of Nursing, where she teaches a course on clinical management of adult patients. She currently serves as a per diem nurse practitioner at the Saban Community Clinic in Los Angeles.
Prior to joining USC, she was an assistant clinical professor in nursing at Columbia University. She also worked as a nurse practitioner at the medical center, providing primary medical care to the university’s health sciences students. In addition, she served as a family nurse practitioner and director of nursing at a community-based clinic in New York’s South Bronx. There she worked to provide evidence-based, preventative and cost-effective health care to a diverse patient population across the lifespan.
Zappas received her bachelor’s, master’s and doctorate degrees in nursing practice from Columbia University. She earned a bachelor’s in animal physiology and neuroscience from the University of California, San Diego.
Columbia University: DPN, Nursing Practice 2012
Columbia University: MSN, Nursing Practice 2009
Columbia University: BSN, Nursing Practice 2007
University of California, San Diego: BS, Animal Physiology 2001
Areas of Expertise (4)
Industry Expertise (6)
Articles & Publications (7)
Over the past 3 decades, type 2 diabetes mellitus in adolescents, those between the ages of 12 and 18 years, has gone from unusual to increasingly common. The prevalence of type 2 diabetes in youth increased by 35% from 2001 to 2009 and has continued to rise. This rise in prevalence is attributed to the increase in pediatric and adolescent obesity. The aim of this article is to provide the nurse practitioner with the tools necessary to treat this unique population using a holistic approach. We address information regarding lifestyle and medical management, growth and development, and the social determinants of health.
Glucagon-like peptide-1 receptor agonists and dipeptidyl-peptidase 4 inhibitors are 2 of 6 second-line medication options in diabetes management according to the 2016 American Diabetes Association guidelines. Providers must take many factors into consideration when choosing a treatment regimen, including patient preference, cost and insurance coverage, efficacy, and tolerability. Side effects, such as hypoglycemia and weight gain, often contribute to lack of control and poor adherence. Glucagon-like peptide-1 receptor agonists and dipeptidyl-peptidase 4 inhibitors are well-tolerated options that improve glycemic control with a low incidence of hypoglycemia and weight gain. In this article we review the similarities, differences, advantages, and disadvantages of the incretin therapies.
Anti-Retroviral Therapy in the Prevention of HIV Transmission among Serodiscordant Couples.
Ulysse, F. & Peters, M.
A 44-year-old female with metastatic cancer pain.
Thyregod, H.G., Rowbotham, M.C., Michelle Zappas, Possehn, J., Berro, M., Petersen, K.L.
Natural history of pain following Herpes Zoster
Petersen, K.L., Peters. M.M, Reda, H.M., Berro, M., Rowbotham, M.C.
Assessment of cutaneous nociceptor function by capsaicin response test during and after acute herpes zoster
Berry, J., Peters, M.M., Rowbotham, M.C., Petersen, K.L.
Symptoms suggesting reflex-sympathetic dystrophy following acute herpes zoster